Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine-specific demethylase 4D (KDM4D) is an epigenetic enzyme belonging to the KDM4 family, specifically characterized by a Jumonji C (JmjC) domain. It catalyzes the removal (demethylation) of di- and trimethyl groups from lysine 9 (H3K9me2/me3) on histone H3, playing important roles in chromatin remodeling and transcriptional regulation[3][4]. Unlike other KDM4 family members, KDM4D features only the JmjN and JmjC domains, lacking the PHD and Tudor domains typically found in KDM4A-C[3][4]. KDM4D is implicated in several cellular processes, including the DNA damage response/repair, differentiation (notably adipogenesis), and hepatic stellate cell activation[1][2][3]. Overexpression or dysregulation of KDM4D has been observed in tumorigenesis and liver fibrosis, suggesting it is a potential therapeutic target in cancer and fibrotic diseases[2][3]. The molecular mechanism involves the removal of repressive histone marks, facilitating gene activation or DNA repair machinery recruitment. Currently, pan-inhibitors of the KDM4 family, such as 8-hydroxyquinoline, target KDM4D's demethylase activity, but selective KDM4D inhibitors and clinical biomarker strategies are still under research[3][5].
Inhibition of H3K9 demethylation (blocking removal of di- and trimethyl marks on lysine 9 of histone H3); Modulation of DNA damage repair pathways (via epigenetic mechanisms)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine-specific demethylase 4D (KDM4D).